On Tuesday, September 26, 2017 at 11:00 AM, the Arkansas State Board of Pharmacy will hold a public hearing in the Arkansas State Board of Pharmacy Offices, 322 South Main, Suite 600, Little Rock, AR 72201. The following regulation changes will be considered:
Regulation 7 – Drug Products/Prescriptions
Proposed changes will update definitions to match FDA definitions and glossary terms to add terms for biological product, biosimilar, biosimilar product, drug, generic drug, and interchangeable biological product. Changes will also clarify language regarding pharmacists’ ability to substitute products that are either generically equivalent, interchangeable biological products or manufacturer authorized generics. Changes will also clarify language regarding pharmacists’ ability to substitute products that are either generically equivalent, interchangeable biological products or manufacturer authorized generics. Language will be added to show that a pharmacist cannot dispense more of a schedule II narcotic medication than a prescriber can prescribe.
Regulation 9 - Pharmaceutical Care/Patient Counseling
Proposed changes will match updated statues to delete language for the Medications Administration Advisory Committee. It will also match updated statutes removing the limitations on the list of medications that can be administered by pharmacists. It will delete a reference that CPR courses must be accredited by the American Heart Association as it does not make sense.
Information about these proposed changes can be found in the PDF links below:
(Deletions are in Red with Strikethrough and additions are Underlined in Blue)
Public comments will be accepted until the conclusion of the public hearing. A copy of the proposed regulation changes can be obtained through our website at http://www.pharmacyboard.arkansas.gov/pharmacy-lawbook by calling (501) 682-0190, writing:
Arkansas State Board of Pharmacy
322 South Main Street, Suite 600
Little Rock, AR 72201,
or by emailing the Board of Pharmacy at email@example.com